RFP released for increasing accrual in therapeutic cancer clinical trials
AcademyHealth is working in partnership with the Leukemia and Lymphoma Society (LLS) to help disseminate their latest Request for Proposals (RFP) under their Equity in Access Research Program.
Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups will fund research studies that will increase our understanding of effective interventions for increasing accrual in therapeutic cancer clinical trials, particularly among underrepresented populations.
LLS is especially interested in proposals that address multilevel barriers that impede clinical trial participation (as many prior studies have focused primarily on mitigating patient-related barriers only). As part of this program, LLS will review submissions to allocate up to $2.5 million per funded study over 5 years, with awards to begin next summer.
Key Dates and Deadlines
The deadline to submit all Letters of Intent is September 12, 2024, at 3:00 PM ET via the LLS Research Portal.
Applicants will be notified whether they are invited to submit a full proposal on November 1, 2024 with full proposals due by January 30, 2025. Grant start date: July 1, 2025.
Questions about this Request for Proposals? Email This email address is being protected from spambots. You need JavaScript enabled to view it..